Caplin M.E. Baudin E. Ferolla P. et al.

Pulmonary neuroendocrine (carcinoid) tumors: european neuroendocrine tumor society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids.

Ann Oncol. 2015; 26: 1604-1620Yoon J.Y. Sigel K. Martin J. et al.

Evaluation of the prognostic significance of TNM staging guidelines in lung carcinoid tumors.

J Thorac Oncol. 2019; 14: 184-192Travis W.D. Brambilla E. Nicholson A.G. et al.

The 2015 world health organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification.

J Thorac Oncol. 2015; 10: 1243-1260Bertino E.M. Confer P.D. Colonna J.E. et al.

Pulmonary neuroendocrine/carcinoid tumors: a review article.

Cancer. 2009; 115: 4434-4441

Management of carcinoid tumors.

Ann Thorac Surg. 2010; 89: 998-1005Sadowski S.M. Christ E. Bédat B. et al.

Nationwide multicenter study on the management of pulmonary neuroendocrine (carcinoid) tumors.

Endocr Connect. 2018; 7: 8-15Stolz A. Harustiak T. Simonek J. et al.

Long-term outcomes and prognostic factors of patients with pulmonary carcinoid tumors.

Neoplasma. 2015; 62: 478-483Filosso P.L. Rena O. Donati G. et al.

Bronchial carcinoid tumors: surgical management and long-term outcome.

J Thorac Cardiovasc Surg. 2002; 123: 303-309Uprety D. Halfdanarson T.R. Molina J.R. et al.

Pulmonary neuroendocrine tumors: adjuvant and systemic treatments.

Curr Treat Options Oncol. Aug 29 2020; 21: 86Baudin E. Caplin M. Garcia-Carbonero R. et al.

Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Ann Oncol. 2021; 32: 439-451Derks J.L. Rijnsburger N. Hermans B.C.M. et al.

Clinical-pathologic challenges in the classification of pulmonary neuroendocrine neoplasms and targets on the horizon for future clinical practice.

J Thorac Oncol. 2021; 16: 1632-1646Nicholson A.G. Tsao M.S. Beasley M.B. et al.

The 2021 WHO classification of lung tumors: impact of advances Since 2015.

J Thorac Oncol. 2022; 17: 362-387Metovic J. Barella M. Bianchi F. et al.

Morphologic and molecular classification of lung neuroendocrine neoplasms.

Virchows Arch. 2021; 478: 5-19Travis W.D. Giroux D.J. Chansky K. et al.

The IASLC lung cancer staging project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM classification for lung cancer.

J Thorac Oncol. 2008; 3: 1213-1223

Neuroendocrine and Adrenal Tumors: NCCN Evidence Blocks, Available at: www.nccn.org. Accessed July 19, 2022 2022.

Sellke F., del Nido P. and Swanson S., Bronchopulmonary carcinoids. Sabiston & Spencer surgery of the chest, 9th edition, 2016, Elsevier Health Sciences, Philadelphia, PA, chap 22.

Gosain R. Groman A. Yendamuri S.S. et al.

Role of adjuvant chemotherapy in pulmonary carcinoids: an NCDB analysis.

Anticancer Res. 2019; 39: 6835-6842Ramirez R.A. Thomas K. Jacob A. et al.

Adjuvant therapy for lung neuroendocrine neoplasms.

World J Clin Oncol. 2021; 12: 664-674Wegner R.E. Abel S. Hasan S. et al.

The role of adjuvant therapy for atypical bronchopulmonary carcinoids.

Lung Cancer. 2019; 131: 90-94Westin G.F.M. Alsidawi S. Leventakos K. et al.

Impact of adjuvant chemotherapy in non-metastatic node positive bronchial neuroendocrine tumors (BNET).

J Clin Oncol. 2017; 35: 8533Afoke J. Tan C. Hunt I. et al.

Is sublobar resection equivalent to lobectomy for surgical management of peripheral carcinoid?.

Interact Cardiovasc Thorac Surg. 2013; 16: 858-863Walters S.L. Canavan M.E. Salazar M.C. et al.

A national study of surgically managed atypical pulmonary carcinoid tumors.

Ann Thorac Surg. 2021; 112: 921-927Machuca T.N. Cardoso P.F. Camargo S.M. et al.

Surgical treatment of bronchial carcinoid tumors: a single-center experience.

Lung Cancer. 2010; 70: 158-162Rea F. Rizzardi G. Zuin A. et al.

Outcome and surgical strategy in bronchial carcinoid tumors: single institution experience with 252 patients.

Eur J Cardio Thorac Surg. 2007; 31: 186-191Altorki N.K. Wang X. Wigle D. et al.

Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503).

Lancet Respir Med. 2018; 6: 915-924Suzuki K. Saji H. Aokage K. et al.

Comparison of pulmonary segmentectomy and lobectomy: Safety results of a randomized trial.

J Thorac Cardiovasc Surg. 2019; 158: 895-907Fox M. Van Berkel V. Bousamra 2nd, M. et al.

Surgical management of pulmonary carcinoid tumors: sublobar resection versus lobectomy.

Am J Surg. 2013; 205: 200-208Yendamuri S. Gold D. Jayaprakash V. et al.

Is sublobar resection sufficient for carcinoid tumors?.

Ann Thorac Surg. 2011; 92: 1774-1779Cattoni M. Vallieres E. Brown L.M. et al.

Sublobar resection in the treatment of peripheral typical carcinoid tumors of the lung.

Ann Thorac Surg. 2019; 108: 859-865

Rahouma M, Kamel M, Narula N, et al. Role of wedge resection in bronchial carcinoid (BC tumors: SEER database analysis, J Thor Dis, 11(4), 1355–62.

Yan T. Wang K. Liu J. et al.

Wedge resection is equal to segmental resection for pulmonary typical carcinoid patients at localized stage: a population-based analysis.

PeerJ. 2019; 7: e7519Filosso P.L. Guerrera F. Falco N.R. et al.

Anatomical resections are superior to wedge resections for overall survival in patients with Stage 1 typical carcinoids.

Eur J Cardio Thorac Surg. 2019; 55: 273-279Bachman K.C. Worrell S.G. Linden P.A. et al.

Wedge resection offers similar survival to segmentectomy for typical carcinoid tumors.

Semin Thorac Cardiovasc Surg. 2022; 34: 293-298Linden P.A. D’Amico T.A. Perry Y. et al.

Quantifying the safety benefits of wedge resection: a society of thoracic surgery database propensity-matched analysis.

Ann Thorac Surg. 2014; 98: 1705-1712Handa Y. Tsutani Y. Mimae T. et al.

Surgical procedure selection for stage I lung cancer: complex segmentectomy versus wedge resection.

Clin Lung Cancer. 2021; 22: e224-e233Del Calvo H. Nguyen D.T. Chan E.Y. et al.

Anatomic pulmonary resection is associated with improved survival in typical carcinoid lung tumor patients.

J Surg Res. 2022; 275: 352-360Brown L.M. Cooke D.T. Jett J.R. et al.

Extent of resection and lymph node assessment for clinical stage T1aN0M0 typical carcinoid tumors.

Ann Thorac Surg. 2018; 105: 207-213